|
Appraisal of Guidelines Research and Evaluation of the guidelines |
||||||
| Appraisal of Guidelines Research and Evaluation criterion |
EULAR [6] |
Ottawa Panel [11] |
ICSI [9] |
CCC [8] |
AAOS [10] |
Schnitzer/ACR [7] |
|
|
||||||
| Scope/purpose |
||||||
| 1. Overall objective(s) specifically described |
2 |
3 |
2 |
3 |
3 |
3 |
| 2. Clinical question(s) specifically described |
3 |
2 |
4 |
2 |
2 |
3 |
| 3. Patients to whom the guideline is meant to apply specifically described |
3 |
4 |
4 |
2 |
3 |
2 |
| Stakeholder involvement |
||||||
| 4. Development group included individuals from all relevant professional groups |
2 |
4 |
2 |
4 |
1 |
1 |
| 5. Patients' views and preferences sought |
1 |
2 |
1 |
4 |
1 |
2 |
| 6. Target users clearly defined |
1 |
4 |
4 |
1 |
4 |
1 |
| 7. Guideline piloted among end users |
1 |
1 |
1 |
1 |
1 |
1 |
| Rigour of development |
||||||
| 8. Systematic methods used to search for evidence |
3 |
3 |
1 |
3 |
2 |
1 |
| 9. Criteria for selecting evidence clearly described |
4 |
4 |
1 |
2 |
1 |
2 |
| 10. Methods used for formulating the recommendations clearly described |
3 |
2 |
1 |
1 |
3 |
1 |
| 11. Health benefits, side effects and risks considered in formulating the recommendations |
4 |
3 |
2 |
4 |
2 |
4 |
| 12. Explicit link between recommendations and supporting evidence |
4 |
4 |
3 |
4 |
2 |
3 |
| 13. Guideline externally reviewed by experts prior to publication |
1 |
3 |
1 |
1 |
2 |
1 |
| 14. Procedure for updating the guideline provided |
1 |
1 |
3 |
3 |
2 |
1 |
| Clarity/presentation |
||||||
| 15. Specific and unambiguous recommendations |
3 |
2 |
3 |
2 |
2 |
1 |
| 16. Different options for diagnosis and/or treatment of the condition clearly presented |
3 |
4 |
3 |
4 |
2 |
3 |
| 17. Key recommendations easily identifiable |
4 |
3 |
4 |
4 |
4 |
1 |
| 18. Guideline supported with tools for application |
2 |
2 |
4 |
2 |
2 |
1 |
| Applicability |
||||||
| 19. Potential organizational barriers in applying the recommendations discussed |
1 |
2 |
2 |
1 |
1 |
1 |
| 20. Potential cost implications of applying the recommendations considered |
1 |
1 |
1 |
4 |
1 |
2 |
| 21. Guideline presents key review criteria for monitoring and audit purposes |
1 |
1 |
3 |
1 |
1 |
1 |
| Editorial independence |
||||||
| 22. Guideline editorially independent from the funding body |
3 |
3 |
1 |
4 |
1 |
1 |
| 23. Conflicts of interest of guideline development members recorded |
1 |
1 |
4 |
4 |
1 |
4 |
|
AAOS, American Academy of Orthopaedic Surgeons; ACR, American College of Rheumatology; CCC, Canadian Consensus Conference; EULAR, European League Against Rheumatism; ICSI, Institute for Clinical Systems Improvement. 1, Strongly disagree; 2, disagree; 3, agree; 4, strongly agree. | ||||||
Poitras et al. Arthritis Research & Therapy 2007 9:R126 doi:10.1186/ar2339 |
||||||